SALT LAKE CITY -- (BUSINESS WIRE) -- BioFire Diagnostics, LLC, bioMérieux’s molecular biology affiliate, today announced that it has recently signed a new purchasing agreement with HealthTrust to provide multi-target molecular diagnostics tests for its nearly 1,400 member facilities.
Under the agreement, HealthTrust will provide its facilities with the opportunity to purchase BioFire’s FilmArray system and its broad infectious disease test menu, including FDA-cleared panels for respiratory, bloodstream and gastrointestinal infections.
The FilmArray system offers clinical laboratories a user-friendly alternative to the time-consuming, labor intensive and technically complex testing methods used today while improving accuracy, timeliness and diagnostic yield. Requiring only two minutes of hands-on time, the FilmArray has about a one-hour turnaround time, and each panel simultaneously tests for 20+ viral, bacterial, parasitic, yeast and/or antibiotic resistance targets, which enables a syndromic approach to infectious diseases.
“We are excited about this new agreement with HealthTrust. Their commitment to strengthening healthcare provider performance and clinical excellence fits perfectly with the FilmArray’s high medical value. This agreement presents a strong opportunity to rapidly expand the FilmArray customer base to a greater number of hospitals, especially across the nation’s leading providers of acute healthcare,” said Randy Rasmussen, bioMérieux corporate vice president of Molecular Biology and CEO of BioFire Diagnostics.
The agreement became effective on June 1, 2014.
About BioFire Diagnostics, LLC
BioFire Diagnostics, LLC, a wholly owned subsidiary of bioMérieux, Inc., manufactures and distributes the user-friendly FilmArray System to hospital-based clinical laboratories across the U.S. and EU. BioFire currently offers the FDA-cleared and CE IVD marked FilmArray Respiratory Panel and FilmArray Blood Culture Identification Panel. The company continues to broaden its FilmArray test menu with regulatory applications for the GI Panel and ongoing development of novel panels.
BioFire holds more than 85 patents related to polymerase chain reaction (PCR), and has used its extensive patent portfolio to successfully market nearly 200 products to the clinical, research and military markets. BioFire customers include the Department of Health and Human Services, the Department of Defense, state and local law enforcement, and researchers and medical technicians across a spectrum of fields and industries.
For further information, please visit www.BioFireDx.com
HealthTrust (legally known as HealthTrust Purchasing Group, L.P.) is committed to strengthening provider performance and clinical excellence through an aligned membership model and the delivery of total cost management solutions, including supply chain solutions and a contract and service portfolio unparalleled in quality, scope and value. HealthTrust (www.healthtrustpg.com) serves nearly 1,400 acute care facilities, 800 ambulatory surgery centers and members in more than 10,600 other locations, including physician practices, long-term care and alternate care sites. Headquartered in Brentwood, Tennessee, HealthTrust is closely integrated with the proven capabilities of Parallon Business Solutions, LLC (www.parallon.com), a leading provider of healthcare business and operational services, including revenue cycle management, workforce and technology solutions.